Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Lifeward Ltd.
AI Executive Summary
AI-powered analysis of 8-K filing content
Lifeward Ltd. completed its acquisition of Oratech Pharma, Inc. on March 25, 2026, marking a strategic expansion into the pharmaceutical sector to enhance its healthcare product portfolio and market position.
Key Takeaways
Lifeward acquired all outstanding equity interests in Oratech Pharma, a subsidiary of Oramed Pharmaceuticals, following a Share Purchase Agreement disclosed on January 12, 2026
The acquisition represents a strategic pivot for Lifeward into the pharmaceutical sector, expanding beyond its current business operations
2 more takeaways
Related Filings (3)
3 more filings from Lifeward Ltd. in the last 90 days